Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Contactin 1 ELISA Kit (AC3304)
Cat.#: ASET-1893
Specifications
Description Mouse Contactin 1 ELISA Kit allows for the in vitro quantitative determination of mouse Contactin 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1726 Mouse PACAP ELISA Kit (AC3137) Quantitative inquiry ASET-1689 Human GABA A Receptor alpha 1 ELISA Kit (AC3100) Quantitative inquiry ASET-1838 Human LST1 ELISA Kit (AC3249) Quantitative inquiry ASET-2194 Guinea Pig Adiponectin ELISA Kit (AC3605) Quantitative inquiry ASET-1280 Human Artemin ELISA Kit (AC2691) Quantitative inquiry ASET-2330 Human POMC ELISA Kit (AC3741) Quantitative inquiry ASET-2187 Mouse Syndecan 4 ELISA Kit (AC3598) Quantitative inquiry ASET-1010 Human HMGN1 ELISA Kit (AC2421) Quantitative inquiry ASET-2317 Rat Ghrelin ELISA Kit (AC3728) Quantitative inquiry ASET-1306 Human Gastrin Releasing Peptide ELISA Kit (AC2717) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket